As of June 2026, according to Mettler Toledo International's current financial statements, the company's 12-month EPS is $42.68. Mettler Toledo International's EPS for 2025 amounted to $42.17, marking an increase from $40.67 in 2024. Mettler Toledo International's earnings per share for the quarterly report ending on Mar 31, 2026 reached $8.35.
The annual EPS for the year 2025 was $42.17, an increase of 3.7% from $40.67 in 2024. The quarterly per-share earnings for the period ending Mar 31, 2026, was $8.35, indicating a 6.5% increase from the same quarter last year. MTD's 12-month EPS stands at $42.68 as of March 2026. Mettler Toledo International's annual EPS in 2024 stood at $40.67, a 12.7% increase year-over-year.
During the last 12 months, Mettler Toledo International has seen an EPS growth of 6.5% (YoY, quarterly). Throughout the last three years, the company had an average EPS growth of 2.8% per year. During the last 5 years, the company had an average EPS growth rate of 10.8%. When measured over a ten-year period, MTD's average EPS growth rate was 12.7%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| TMO Thermo Fisher Scientific Inc | 25.76 | 7.2% | 0% | 2% |
| MTD Mettler Toledo International Inc | 27.1 | 3.7% | 2.8% | 10.8% |
| XYL Xylem Inc | 27.46 | 7.1% | 25.9% | 22.8% |
| DHR Danaher Corp | 34.48 | -4.9% | -19.7% | 0.4% |
| WAT Waters Corp | 45.27 | 0.5% | -2.9% | 5.2% |
| BIO Bio-Rad Laboratories Inc | 46.37 | 142.6% | N/A | -26.3% |
| BRKR Bruker Corp | N/A | -119.7% | N/A | N/A |
| HBIO Harvard Bioscience Inc | N/A | -357.1% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.